Local Anaesthetic Effects of Transcutaneous Amitriptyline
1 other identifier
interventional
16
1 country
1
Brief Summary
The aim of this study is to assess the local anaesthetic effects of amitriptyline applied on the skin of human volunteers, considering the differential effects on mechanic and thermic sensitivity, the local and general tolerance, and the systemic absorption of the drug. The solution used for dilution of amitriptyline is the only one known to allow transcutaneous absorption of the drug \[1\]. Considering that the peripheral sensitive fibre is a possible site of action of tricyclic antidepressants for relieving neuropathic pain \[2,3\], this is a first step study before further assessment of the therapeutic effects of transcutaneous amitriptyline.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1 healthy-volunteers
Started Nov 2005
Longer than P75 for phase_1 healthy-volunteers
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2005
CompletedFirst Submitted
Initial submission to the registry
July 20, 2006
CompletedFirst Posted
Study publicly available on registry
July 21, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2007
CompletedApril 4, 2013
April 1, 2013
July 20, 2006
April 2, 2013
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- Healthy volunteers
You may not qualify if:
- history of intolerance to amitriptyline, lidocaine or prilocaine
- cardiac predisposition to intolerance to tricyclic antidepressants
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre de Pharmacologie Clinique /Cic
Clermont-Ferrand, Auvergne, 63003, France
Related Publications (4)
Kissin I, McDanal J, Xavier AV. Topical lidocaine for relief of superficial pain in postherpetic neuralgia. Neurology. 1989 Aug;39(8):1132-3. doi: 10.1212/wnl.39.8.1132-a. No abstract available.
PMID: 2761713BACKGROUNDSawynok J, Esser MJ, Reid AR. Antidepressants as analgesics: an overview of central and peripheral mechanisms of action. J Psychiatry Neurosci. 2001 Jan;26(1):21-9.
PMID: 11212590BACKGROUNDMcQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain. 1996 Dec;68(2-3):217-27. doi: 10.1016/s0304-3959(96)03140-5.
PMID: 9121808BACKGROUNDDuale C, Daveau J, Cardot JM, Boyer-Grand A, Schoeffler P, Dubray C. Cutaneous amitriptyline in human volunteers: differential effects on the components of sensory information. Anesthesiology. 2008 Apr;108(4):714-21. doi: 10.1097/ALN.0b013e3181672632.
PMID: 18362604RESULT
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Claude DUBRAY, Pr
CENTRE DE PHARMACOLOGIE CLINIQUE
- STUDY DIRECTOR
Christian DUALE, Dr
CENTRE DE PHARMACOLOGIE CLINIQUE
- STUDY DIRECTOR
PICKERING gisele, Dr
CENTRE DE PHARMACOLOGIE CLINIQUE
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 20, 2006
First Posted
July 21, 2006
Study Start
November 1, 2005
Study Completion
December 1, 2007
Last Updated
April 4, 2013
Record last verified: 2013-04